Find the Perfect Plan for Your Investment Journey
Last Price
52 Week Range
CN¥18.88 - CN¥27.60
Next Earnings Date
Aug 26 2025 (Estimate)
Next Earnings Date
Aug 26 2025 (Est.)
Last Price
Market Cap | CN¥37.77B |
EV | CN¥39.10B |
Shares Outstanding | 1.98B |
Beta | 0.57 |
Analyst Rating | BUY |
Analyst Target Price | CN¥29.00 |
P/E 2025E | 22.47x |
P/Revenue 2025E | 5.45x |
Revenue | 13.70% |
EPS | 25.40% |
Operating Cash Flow | -5.80% |
Free Cash Flow | -110.50% |
Revenue | 11.70% |
EPS | 11.80% |
Operating Cash Flow | 48.60% |
Free Cash Flow | - |
Gross Margin 2025E | 53.98% |
Net Profit Margin 2025E | 24.36% |
ROE 2025E | 13.67% |
ROCE 2024 | 14.78% |
DPS 2025E | CN¥0.10 |
Payout Ratio 2025E | 11.77% |
Div. Yield 2025E | 0.52% |
DPS Last 3Y CAGR | 13.00% |
Price
%
1M
3M
6M
1Y
3Y
5Y
Beijing Tiantan Biological Products Co., Ltd.
600161
Sector
Healthcare
Industry
Biotechnology
CEO
Fu, Dao Xing
Employees
5,298
Website
www.tiantanbio.comIPO Date
1998-06-16
Headquarters
Courtyard No. 2, Shuangqiao Road, Chaoyang District, Beijing 100024, China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved